Figure A
Olopatadine Hydrochloride Spray, Metered
Product Images NDC 60505-0845
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 60505-0845). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure B
Figure C
Figure D
Figure E
Figure Fjpg
Figure G
Olopatadine-hcl (Olopatadine HCl)
Bottle.jpg (Bottle)
This is a description of a nasal spray medication for intranasal use only. The medication is olopatadine HCI and each spray contains 665mcg of the medication, with 240 metered sprays in total. The net fill weight is 30.5 and it also contains 0.01% benzalkonium chloride as a preservative. It is manufactured by Apotex Corp and must be stored at 4°C to 25°C (38°F to 77°F).*
Olop-carton.jpg (Olop Carton)
This description pertains to a nasal solution (nasal spray) of Olopatadine HCI, used for adults and adolescents aged 12 years and older. The preferable dosage for adults and adolescents is two sprays per nostril, once a day. For children aged 6-11 years, one spray per nostril is recommended thrice a day. The metered dose is of 665 meg with an inactive Sodium chloride, Sodium hydroxide, and purified water. The product boasts a net fill weight of 305 gm or 240/200 metered sprays depending on the version you have. The prescription should be dispensed with enclosed patent instructions. The product is manufactured in Canada for Apotex Cap.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
